Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Queener

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Metabolism: Clinical and Experimental|April 1, 1975
Calcitonin: a general surveyS F Queener, N H Bell
Antimicrobial Agents and Chemotherapy|July 1, 1991
Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugsM C Broughton, S F Queener
Bioorganic & Medicinal Chemistry|October 13, 2001
Synthesis of 2,4-diamino-6-(thioarylmethyl)pyrido[2,3-d]pyrimidines as dihydrofolate reductase inhibitorsA Gangjee, O Adair, S F Queener
Journal of Medicinal Chemistry|February 14, 1997
Synthesis and dihydrofolate reductase inhibitory activities of 2,4-diamino-5-deaza and 2,4-diamino-5,10-dideaza lipophilic antifolatesA Gangjee, R Devraj, S F Queener
Journal of Medicinal Chemistry|February 14, 1997
Synthesis and biological evaluation of nonclassical 2,4-diamino-5-methylpyrido[2,3-d]pyrimidines with novel side chain substituents as potential inhibitors of dihydrofolate reductasesA Gangjee, A Vasudevan, S F Queener
Journal of Medicinal Chemistry|November 7, 1998
6-Substituted 2,4-diaminopyrido[3,2-d]pyrimidine analogues of piritrexim as inhibitors of dihydrofolate reductase from rat liver, Pneumocystis carinii, and Toxoplasma gondii and as antitumor agentsA Gangjee, Y Zhu, S F Queener
Journal of Medicinal Chemistry|September 25, 1997
Conformationally restricted analogues of trimethoprim: 2,6-diamino-8-substituted purines as potential dihydrofolate reductase inhibitors from Pneumocystis carinii and Toxoplasma gondiiA Gangjee, A Vasudevan, S F Queener
Advances in Experimental Medicine and Biology|January 1, 1993
Synthesis and biological activity of tricyclic, conformationally restricted analogs of lipophilic pyrido[2,3-d]-pyrimidine antifolatesA Gangjee, F Mavandadi, S F Queener
Journal of Medicinal Chemistry|July 8, 1999
Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidinesA Gangjee, O Adair, S F Queener
Drug Design and Discovery|August 31, 1999
Inhibition of dihydrofolate reductases from Toxoplasma gondii, Pneumocystis carinii, and rat liver by rotationally restricted analogues of pyrimethamine and metoprineA Rosowsky, S F Queener, V Cody
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Metabolism: Clinical and Experimental|April 1, 1975
Calcitonin: a general surveyS F Queener, N H Bell
Antimicrobial Agents and Chemotherapy|July 1, 1991
Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugsM C Broughton, S F Queener
Bioorganic & Medicinal Chemistry|October 13, 2001
Synthesis of 2,4-diamino-6-(thioarylmethyl)pyrido[2,3-d]pyrimidines as dihydrofolate reductase inhibitorsA Gangjee, O Adair, S F Queener
Journal of Medicinal Chemistry|February 14, 1997
Synthesis and dihydrofolate reductase inhibitory activities of 2,4-diamino-5-deaza and 2,4-diamino-5,10-dideaza lipophilic antifolatesA Gangjee, R Devraj, S F Queener
Journal of Medicinal Chemistry|February 14, 1997
Synthesis and biological evaluation of nonclassical 2,4-diamino-5-methylpyrido[2,3-d]pyrimidines with novel side chain substituents as potential inhibitors of dihydrofolate reductasesA Gangjee, A Vasudevan, S F Queener
Journal of Medicinal Chemistry|November 7, 1998
6-Substituted 2,4-diaminopyrido[3,2-d]pyrimidine analogues of piritrexim as inhibitors of dihydrofolate reductase from rat liver, Pneumocystis carinii, and Toxoplasma gondii and as antitumor agentsA Gangjee, Y Zhu, S F Queener
Journal of Medicinal Chemistry|September 25, 1997
Conformationally restricted analogues of trimethoprim: 2,6-diamino-8-substituted purines as potential dihydrofolate reductase inhibitors from Pneumocystis carinii and Toxoplasma gondiiA Gangjee, A Vasudevan, S F Queener
Advances in Experimental Medicine and Biology|January 1, 1993
Synthesis and biological activity of tricyclic, conformationally restricted analogs of lipophilic pyrido[2,3-d]-pyrimidine antifolatesA Gangjee, F Mavandadi, S F Queener
Journal of Medicinal Chemistry|July 8, 1999
Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidinesA Gangjee, O Adair, S F Queener
Drug Design and Discovery|August 31, 1999
Inhibition of dihydrofolate reductases from Toxoplasma gondii, Pneumocystis carinii, and rat liver by rotationally restricted analogues of pyrimethamine and metoprineA Rosowsky, S F Queener, V Cody
Pageof 13